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Abstract
The Toll-Like Receptors (TLRs) are proteins involved in the immune system that increase cytokine levels when triggered.
While cytokines coordinate the response to infection, they appear to be detrimental to the host when reaching too high
levels. Several studies have shown that the deletion of specific TLRs was beneficial for the host, as cytokine levels were
decreased consequently. It is not clear, however, how targeting other components of the TLR pathways can improve the
responses to infections. We applied the concept of Minimal Cut Sets (MCS) to the ihsTLR v1.0 model of the TLR pathways to
determine sets of reactions whose knockouts disrupt these pathways. We decomposed the TLR network into 34 modules
and determined signatures for each MCS, i.e. the list of targeted modules. We uncovered 2,669 MCS organized in 68
signatures. Very few MCS targeted directly the TLRs, indicating that they may not be efficient targets for controlling these
pathways. We mapped the species of the TLR network to genes in human and mouse, and determined more than 10,000
Essential Gene Sets (EGS). Each EGS provides genes whose deletion suppresses the network’s outputs.
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Introduction
Signal transduction pathways, such as the Toll-Like Receptors
(TLR) signaling pathways, are an essential component of the
innate and acquired immune response [1]. The TLRs are highly
conserved membrane receptors that recognize specific molecules
of bacterial and viral origin. When triggered, the TLRs recruit
adaptor molecules such as MyD88 or TICAM [2,3], and initiate
signaling cascades leading to the activation of transcription factors
(TFs). Different stimuli activate specific sets of TFs, which regulate
the necessary response of the cell.
Many studies have established the significant role TLRs play
within the immune system: detection of pathogenic particles [3],
signal transduction [4], and activation of TFs [5]. For some
infections, recent works have shown that the TLRs provoke
deleterious side effects to the host by increasing cytokine
concentrations. They have established that mice deficient in
one of the TLRs had a better response to infection: TLR4{={
for C. rodentium [6], TLR2{={ for P. gingivalis [7], and
TLR3{={ for Phlebovirus [8]. Targeting a TLR enables to
decrease cytokine concentrations leading to an increased
survival rate. These results demonstrate that regulating cytokine
production may be a good strategy to improve responses to
infections. One has to keep in mind that the deletion of a TLR
has an overall negative effect on the host on the long term.
Polymorphisms in the TLRs significantly increase the suscep-
tibility to opportunistic infections [9], emphasizing the key role
the TLRs play in the immune system. It is not clear, however,
how targeting other components of the TLR pathways can
improve the responses to infections.
The ihsTLR v1.0 model is a stoichiometric representation of the
human TLR signaling pathways that follows six outputs: AP-1,
CREB, IRF3, IRF7, Reactive Oxygen Species (ROS), and NF-kB
(Table 1) [10]. These compounds play a major role in the response
to infection. AP-1 is involved in proliferation and differentiation,
and activates both pro- and anti-apoptotic responses [11]. CREB
responds to growth factor signals and regulates cell survival and
proliferation [12]. IRF3 and IRF7 are activated during viral
infections and are critical for the activation of Type I IFN [13].
NF-kB plays a role in both innate and adaptive immune responses
by regulating B- and T-cells development, and is involved in the
inflammatory response [14]. ROS, which is the only output not
being a TF, are highly reactive chemicals containing oxygen. ROS
regulate signal transduction pathways at small dose, provoke
oxidative damage at high dose, and are actively involved in wound
healing processes [15].
The stoichiometric reaction format has been used extensively to
represent metabolic [16,17] and signaling networks [18–20].
Alternatively, signal transduction pathways have been modeled by
Petri nets [21] and Boolean logic [22]. The stoichiometric reaction
format has led to the development of various methods, such as
Extreme Pathway (EP) analysis [23], Flux Balance Analysis (FBA)
[24], and Minimal Cut Sets (MCS) [25]. An MCS for an objective
reaction is a minimal set of reactions whose knockout disables that
function. This notion is helpful for studying robustness and
epistasis relationships in complex networks. FBA can easily
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however, this approach becomes computationally challenging for
large-scale networks. EP analysis can bypass this difficulty and has
successfully been applied to the E. coli and human metabolic
models [25–27].
In this study, we generated MCS for the ihsTLR v1.0 model.
We encountered 2,669 MCS showing that each output uses
different components of the TLR network. We partitioned the
model in modules, which group reactions having similar functions.
We determined which modules the MCS targeted, allowing to
identify epistatic relations between components of the network. It
appeared from our analysis that the TLRs were not the primary
targets of the MCS, implying the TLR pathways are better
manipulated by disabling targets downstream of the TLRs. We
extended the MCS to the notion of Essential Gene Sets (EGS). EGS
are sets of genes whose deletion ensures the knockout of an output.
We assessed the impact of these deletions over the network, in
term of species, reactions, and modules perturbed. We generated
more than 10,000 EGS for both human and mouse. The EGS
provide valuable information when designing knockout experi-
ments by identifying gene deletions that have minimal impact on
the network. They also identify essential genes that have a key role
in the activation of a particular output of the TLR pathways.
Results
2,669 minimal cut sets produced 68 different signatures
The ihsTLR v1.0 model comprises 781 species involved in 963
reactions. We extended the model to 1,956 reactions to account
for irreversibility and sink reactions. The over-approximation flux
cone   K K of the model yielded 1,598,509 EPs. We computed hitting
sets for each output reaction and reduced them to minimality. We
obtained a total of 2,669 MCS for all outputs (Table 2) (see
Materials and Methods). The number of MCS greatly varies
across outputs: it ranges from 6 for NF-kB(2) to 1,042 for IRF7.
We grouped the reactions from the ihsTLR v1.0 into distinct
modules. Reactions in the same module generally have the same
function or lead to the same end product. These functions usually
consist in activating a specific protein or in transmitting a stimulus
to another part of the network. The modules determine a partition
of the set of all reactions (see Fig. 1 for a module partition of a toy
network). We derived 34 modules from the map of the TLR
network (Fig. S1 by Li et al. [10]). This map clusters biologically
related reactions that share substrates or products. Tables 3 and S1
provide the list and a description of the modules hit by MCS. Ten
of the 34 modules are never targeted by any MCS: Akt, Caspase 9,
Cytoplasmic MAPK substrates, FADD, IL-1, IL-1 cascade, IKK, NOD,
PKR, and SIGIRR.
Three hypotheses are made. First, reactions in these modules
may not be included in any EP, rendering them ‘‘unusable’’ in a
cut set. The analysis of the partial flux cone shows, however, that
the reactions in these modules are present in at least 1 EP. Second,
these modules may not be essential for the activation of the
outputs. Third, too many reactions from these modules may need
to be targeted simultaneously to observe an effect. This last
hypothesis reflects a limitation of the algorithm, which did not
detect MCS of more than 8 reactions in our study.
The mapping of reactions to modules enabled to determine the
signature of each MCS (see Fig. 1 for a graphical illustration of this
concepts in a small network). The signature of an MCS is the list of
modules it targets, i.e. the modules containing reactions hit by the
MCS. We obtained one signature per MCS. We were able to
reduce the 2,669 MCS to 68 distinct signatures indicating that
most of the MCS target the same combinations of modules. We
define as the profile of an output the set of distinct signatures
obtained for that output. We generated profiles for each output
(Fig. 2). In addition to presenting the signatures, the profiles
display distributions showing the number of times each signature is
encountered (top) and how many times each module is hit by an
MCS (right). These distributions emphasize the most frequent
signatures and the modules that are targeted the most, respectively
(cf. Fig. 1). The AP-1(2) and NF-kB(2) profiles are not shown in
Figure 2. The AP-1(2) profile is identical to the AP-1 one, minus
the 7-th signature. The NF-kB(2) profile is composed of only one
signature targeting the NF-kB module.
Each reaction in an MCS belongs to a module and some of
these reactions may belong to the same module. Hence, an MCS
may target the same module through different reactions. We
define the MCS Module Cardinality (MMC) as the number of
modules an MCS hits. Figure 3 shows the MMC distribution for
the outputs. Each distribution describes how many MCS target n
modules simultaneously for a given output (nƒ4 for all MCS). In
addition, the colors describe which modules are targeted, as well as
their relative importance. The distributions enable to immediately
identify modules that are targeted alone (e.g. Common metabolites,
Table 1. Output reactions of the ihsTLR v1.0 model.
Output name Description
AP-1 Binding of the Jun/Fos dimer to the AP-1 site
AP-1(2) Binding of the Jun/Jun dimer to the AP-1 site
CREB Binding of CREB to the CRE site
IRF3 Binding of phosphorylated IRF3 to the ISRE site
IRF7 Binding of phosphorylated IRF7 to the ISRE site
NF-kB Dissociation of the NF-kB/IkBa complex
NF-kB(2) Dissociation of the NF-kB/IkBb complex
ROS Formation of the NADPH oxidase complex, the p47phox
subunit being phosphorylated three times
ROS(2) Formation of the NADPH oxidase complex, the p47phox
subunit being phosphorylated eight times
doi:10.1371/journal.pone.0031341.t001
Table 2. Basic statistics about the MCS.
Output MCS Cardinality Signatures Module hit
AP-1 189 1–7 10 7
AP-1(2) 185 1–7 9 7
CREB 510 1–8 18 9
IRF3 22 1–3 6 5
IRF7 1,042 1–8 18 8
NF-kB3 5 1 1 – 5 1 0 5
NF-kB(2) 6 1–3 1 1
ROS 138 1–6 21 13
ROS(2) 226 1–5 20 12
Total 2,669 1–8 68 24
The cardinality of an MCS is defined as the number of reactions present in the
MCS. Its signature corresponds to the list of modules (cf. Table 3) that are
targeted by the MCS. The table lists the number of distinct signatures obtained
for each output reaction, as well as the total number of targeted modules.
doi:10.1371/journal.pone.0031341.t002
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modules (e.g. PDK1 for ROS, Early endosome for IFR7, or MyD88 for
AP-1 and AP-1(2)). Interestingly, the cardinality of the MCS does
not seem to be a good indicator of the cardinality of the signature
(i.e. the number of modules targeted simultaneously). Particularly
for the CREB, ROS(2), NF-kB, and IRF7 outputs, many MCS of
high cardinality hit few modules at a time (Fig. S1). This
observation seems to indicate that modules are fairly robust to
reaction deletions.
More than 10,000 Essential Gene Sets generated for
human and mouse
We define an Essential Gene Set (EGS) as a set of genes whose
deletion renders a predefined output non-producible. EGS can be
seen as the gene version of MCS. Instead of providing reactions,
EGS procure the list of genes whose knockout stops the production
of an objective, which is a valuable information when designing
knockout experiments. We can clearly disable genes in an EGS
(e.g. with siRNA), and the corresponding objective reaction, unlike
reactions in an MCS (Fig. 4). EGS also summarize MCS since a
common gene may be able to disable multiple reactions. Gene
knockouts are more optimal than reaction knockouts. Finally, EGS
identify essential genes that have a key role in the activation of a
particular output of the TLR model. Even though genes have
much slower dynamics than reactions in the TLR model, we do
not perform any dynamical analysis of these pathways with the
EGS. Transient behaviors of the network do not affect the
producibility of the outputs.
The ihsTLR v1.0 model is based on human pathways. The
TLRs and their pathways are however highly conserved across
species and especially among vertebrates [28]. Since human and
mouse share 90% of their genome [29], we generated Gene-
Protein-Reaction (GPR) associations for the two organisms.
Moreover, most data translation to human comes from mouse.
We recognize that there are some significant differences between
the human and mouse TLR pathways, notably in the TLR10
pathway [30]. This particular pathway was however not involved
in the MCS we encountered, therefore limiting the inconsistencies
in the mouse results. We were able to assign 341 and 335 genes to
570 and 567 species of the model in human and mouse,
respectively (Dataset S1). The discrepancy in the number of
relationships and genes is explained by different numbers of
isoenzymes or subunits in both species. We used the MCS to
generate initially 42 and 44 EGS for human and mouse,
respectively (see Materials and Methods). The number of EGS is
similar since all the proteins of the network have homologs in both
Figure 1. Schematic representation of a signaling network. The left part of the figure shows a toy model of a signaling network. Nodes and
edges represent species and reactions, respectively. The network contains two inputs (top incoming arrows) and two outputs (bottom outgoing
arrows). The set of reactions is partitioned in four modules (A, B, C, and D). Each crossed reaction belongs to an MCS for output O (only 4 MCS are
shown for simplicity). Each color denotes a different MCS. Targeting simultaneously the two red-crossed reactions disables O. This MCS describes an
epistatic relation between modules A and B. The upper-right diagram represents the profile of output O, i.e. the collection of distinct signatures
obtained from the MCS. The profile displays distributions showing the frequency of each signature (top) and how many times each module is hit by
an MCS (right). In our example, the first signature is obtained twice (red and blue MCS). Module A is hit three times: twice by the first signature and
once by the second one. The lower-right diagram represents the MCS Module Cardinality (MMC) distribution of O, which shows the number of MCS
targeting n module(s) simultaneously (n~1,2). The targeted modules are color coded in relative proportion. Among all the MCS of cardinality 2, half
of the targeted reactions belong to module A.
doi:10.1371/journal.pone.0031341.g001
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both species, 16 EGS involved genes directly coding for the
outputs and required no further validation (i.e. ‘‘evident’’ EGS).
We were also able to confirm a total of 12 EGS through literature
searches (Tables 4 and S2). In summary, we were able to find
evidence to validate *66% of all EGS.
Only AP-1(2) failed to produce EGS targeting specifically this
output. This is easily explained as disabling AP-1(2) requires to
knock out the Jun protein. This protein is however essential for the
formation of the Jun/Fos complex (i.e. AP-1, cf. Table 1). Hence,
EGS found for AP-1(2) hit AP-1 as well. Since the ROS/ROS(2)
and NF-kB/NF-kB(2) outputs are also closely related, many of the
EGS for one of the outputs disable the other one.
Genes in the EGS are part of the MyD88-dependent pathway
(e.g. MyD88, TRAF6, TLR7, TLR8, TLR9), MyD88-independent
pathway (e.g. TICAM1, TBK1, IKKE), and the MAPK pathways
(e.g. MAPK8, MAP2K4, MAP2K7). The initial EGS we computed
contain in general a small number of genes (see Table S2).
Disregarding the evident EGS, most of the remaining EGS
contain no more than 3 genes (*80%). It is experimentally
difficult to knock out more than two genes at a time. Even with this
limitation, *68% of the non-evident EGS remain experimentally
usable.
We used the 42 and 44 initial EGS to generate a second set of
EGS capable of disabling any combination of outputs. Combining
the initial EGS gave us a total of 10,377 and 11,577 gene sets
targeting any desired set of outputs in human and mouse,
respectively. In addition, we computed the species, reaction, and
module impacts of each EGS, i.e. the number of species, reactions,
and modules disabled after deletion of the EGS. These values
estimate the global impact of the EGS. We enumerated the 801
EGS that target the power set of outputs with minimal impact in
both species (Dataset S2). The minimal EGS target a specific set of
outputs while affecting a minimum number of species, reactions,
and modules.
Discussion
The TLR network is a complex set of signaling reactions which
upon triggering leads to the activation of various TFs and release
of cytokines. These cytokines, which coordinate the response to
infection, also provoke collateral damage when reaching too high
levels. Several studies have shown that the knockout of particular
TLRs were beneficial for hosts undergoing specific infections, as it
reduces cytokine concentrations [6–8]. It is not clear, however,
how targeting other components of the TLR pathways can
improve the responses to infections.
We studied the ihsTLR v1.0 model [10] and generated 2,669
MCS for all outputs of the network. The MCS were organized into
68 distinct signatures, revealing epistatic relationships in the
network (Figs. 2 and 3). Epistasis was not examined at the reaction
level, but rather at the module level. We focused our attention on
the sub-systems of the network whose joint perturbation disabled
an output. Epistatic relationships reveal the major functions
needed to ensure the production of the outputs. For example,
IRF3 production is shut down by perturbing the transmission of
the stimuli from the TLRs via the TICAM adaptor molecules,
while disabling the activation of both PDK1 and PKCf stops ROS
production. Figure 3 shows how the network is being used for each
output. Based on the output, different sets of modules are targeted.
This difference in module composition suggests that each output
uses different pathways of the network.
Since the TLRs are the inputs of the TLR network, one would
expect that they control the outputs. Among the 2,669 MCS, only
183 targeted directly one of the TLRs. Even though the TLRs are
critical in the response to infection, it appears that disabling them
is inefficient to accurately control the network’s outcome.
Searching for targets downstream of the TLRs appears to be a
better strategy to efficiently shut down a desired pathway. This
observation may seem contradictory to previous works showing
that the deletion of the TLRs perturbed reactions within these
pathways. These studies, however, analyzed the TLR pathways for
specific infections. Here, the MCS ensure the suppression of an
objective regardless of the set of triggered TLRs, which makes
MCS non-specific to a particular infection. The low frequency of
the TLRs appearing in the MCS may also be due to redundancies
in the TLR pathways, already highlighted in [10]. In their study,
Li et al. showed that some outputs of the TLR network (i.e. NF-kB,
CREB, AP-1, and ROS) are activated by at least 11 different
receptors. Hence, knocking out one TLR will not affect these
outputs since the remaining receptors can potentially activate
them. One would need to disable all the TLRs to ensure that the
outputs can no longer be activated. This extreme solution has also
the biological disadvantage of disabling all TLR pathways, making
the host highly susceptible to infection. It is difficult to establish
clear consequences of TLR knockouts on the network. We can
only perform this analysis for IRF7. The MCS confirmed that the
knockout of TLR7, TLR8, and TLR9 shuts down IRF7
activation, which disables the transcription of Type I IFN genes
Table 3. Modules of the TLR network.
Module Function
AP-1 Binding of AP-1 complex to AP-1 site
Btk Activation of Btk
Calcium dependent cascade Activation of calcium/calmodulin-dependent
protein kinase
Common metabolites Transport of metabolites into the cytoplasm
CREB Binding of CREB to CRE site
Cytoplasm-Nucleus transport Transport of various species into the nucleus
Early endosome Degradation and recycling of receptors
GSK3b Activation of GSK3b
IFN genes Binding of IFN with the ISRE site
KSR1 Activation of the MAPK pathway
Ligands Import of ligands in the system
Lipids Lipids phosphorylation
MAPK Transmission of stimuli
MAP3K7 Transmission of stimuli
MyD88 Transmission of stimuli from the TLRs
NF-kB Dissociation of NF-kB from IkB
NF-kB phosphorylation Activation of NF-kB
PDK1 Activation of PDK1
PKCf Activation of PKCf
Rho GTPases Activation of GTPases
ROS production Formation of the NADPH oxidase complex
Thioredoxin Oxidation and reduction of thioredoxin
TICAM Transmission of stimuli from the TLRs and
activation of IRF3
TLR Binding of ligands with the TLRs
Function of the modules involved in the TLR network [10]. Only modules hit by
MCS are shown. A short description of these modules is available in Table S1.
doi:10.1371/journal.pone.0031341.t003
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macrophages [31].
Gene deletions can be performed to ensure the knockout of the
outputs of the TLR network. Adequate combinations of genes,
which we provide with the EGS, enable to target a specific set of
outputs. Using the MCS, we generated 10,377 and 11,577 EGS
for human and mouse, respectively. Since we considered a human
TLR network, discrepancies may arise in the mouse EGS. This
limiting factor is attenuated as the MCS did not involve any
human specific pathway. The EGS identify essential genes for the
activation of the network’s outputs (Table S2). For example,
TBK1 and IKKE seem to be essential for the activation of IRF3
and IRF7, while PDK1 and PKCf appear to be key in the
production of ROS.
To the best of our knowledge, this study is the first attempt to
use MCS for the study of signaling networks in the form of a
stoichiometric model. MCS have initially been developed for the
study of metabolic networks. Their application to the E. coli and H.
sapiens metabolic networks have given interesting results [25–27].
Even though MCS were not intended for signaling networks, their
usage on such networks gives promising results. Indeed, our
validation of the EGS (derived from the MCS) showed that about
80% of them concord with biological observations. This validation
process indicates that the usage of MCS on the ihsTLR v1.0 model
provides results that are biologically relevant.
Li et al. defined DIOS pathways based on a pairing of inputs and
outputs [10]. In our study, MCS and EGS are output-specific.
However, we can compare the two approaches based on which
output is controlled by the DIOS pathways. By using FBA, Li et al.
only provided single reactions controlling a pathway. We analyzed
EPs to determine sets of reactions, or MCS, disabling a particular
output and to study epistatic relationships between components of
the system. We obtained MCS containing up to 8 reactions.
Obtaining similar results with FBA would be computationally very
expensive for large-scale networks, such as the ihsTLR v1.0 model.
In addition to control reactions we also provided (sets of) control
genes, i.e. the EGS. In addition, Li et al. focused on single DIOS
pathways, while we also describe gene sets capable of disabling
multiple outputs.
We observed similarities with the essential reactions as reported
in Table S6 by Li et al. [10]. Our EGS list that the evident
knockout of IRF3 is capable of disabling the production of this
output. IRF3 is also involved in all the essential reactions of the
IRF3 DIOS pathway. A similar result is observed with IRF7. Four
out of the 5 essential reactions in the ROS production DIOS pathway
are listed in our MCS. Our EGS list that the knockout of IKKa,
IKKb, and IKKc disables the NF-kB output. These genes are the
subunits of the IKK complex, which is involved in essential
reactions of the RIP1, NOD1, NOD2, and RIP2/TRIP6/TRAF2
DIOS pathways (two reactions in each pathway). These 4 DIOS
pathways each control NF-kB [10]. Interestingly, we obtain
similar results even after increasing the number of reactions in the
model.
As suggested by Li et al., metabolites seem to play a crucial role
in signal transduction [10]. Only targeting the Common metabolite
module, which perturbs the normal exchange of metabolites
between the extracellular and cytoplasmic compartments, can
disable most of the outputs. Interestingly, no other module has
such effect, highlighting the pivotal role of metabolite transfers. In
many cases, perturbations of cytoplasmic transports are associated
with the targeting of the Cytoplasm-Nuclear Transport module (Fig. 2).
This result emphasizes again the major role metabolites play in
Figure 2. Profiles obtained for seven of the output reactions: AP-1, CREB, IRF3, IRF7, NF-kB, ROS, and ROS(2). Each vertical line
represents a distinct signature, i.e. the list of modules hit by an MCS. The profiles also display distributions showing the number of times each
signature is encountered (top) and how many times each module is hit by an MCS (right). These distributions emphasize the most frequent
signatures and the most targeted modules, respectively (cf. Fig. 1). Profiles of AP-1(2) and NF-kB(2) are omitted. The AP-1(2) profile is identical to the
AP-1 one, minus the 7-th signature. The NF-kB(2) profile is composed of a single signature targeting the NF-kB module.
doi:10.1371/journal.pone.0031341.g002
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Transport module is never targeted on its own, it appears that the
most critical reactions in these pathways occur within the
cytoplasm.
Surprisingly, none of the MCS targeted the IKK module. The
NF-kB and NF-kB(2) outputs can however be disabled by
targeting this module, which activate the IKK complex. IKK is
a protein kinase formed of three subunits that phosphorylates IkB,
the inhibitory proteins of NF-kB [32]. Members of the IkB family
bind to NF-kB to form an inactive complex. Two IkB proteins are
present in the model: IkBa and IkBb, which correspond to the
NF-kB and NF-kB(2) outputs, respectively. After phosphorylation
by IKK, the NF-kB/IkB complex rapidly dissociates, leaving NF-
kB free for activation. The phosphorylation of IKK occurs in the
model through 11 independent reactions. However, the MCS
algorithm failed to generate MCS with more than 8 reactions,
hence being unable to produce some targeting IKK. One can argue
that preventing the phosphorylation of IKK in vivo would require
to shut down at least 11 different reactions each using a different
enzymatic complex, which may not be an easy task. A simpler way
to prevent IKK phosphorylation would be to disable the formation
of the complex by knocking out one of its three subunits. This
solution was not detected since the reaction leading to the
formation of IKK is absent from the ihsTLR v1.0 model. Adding
this reaction would have certainly provided us with more MCS for
the NF-kB outputs, thus increasing the number of EGS. Being
able to generate MCS of higher cardinality represents an
improvement that would greatly benefit the analysis of stoichio-
metric reconstructions. However, we would like to emphasize that
MCS already give us access to information other techniques are
unable to provide.
An additional limitation arises from the ihsTLR v1.0 model
itself. This model is derived from the map of the TLR pathways
developed by Oda and Kitano [10,33]. However, this map does
Figure 3. Distributions of the MCS Module Cardinality (MMC). Each reaction in a MCS belongs to a module and some of these reactions may
belong to the same module. Hence, an MCS may target the same module through different reactions. The MMC represents the number of distinct
modules an MCS hits. The bars in each plot represent the number of MCS targeting simultaneously n modules (n~f1,2,3,4g). No MCS targets more
than 4 modules at a time. The colors describe which modules are targeted, as well as their relative importance. The distributions enable to
immediately identify modules that are targeted alone (e.g. Common metabolites, ROS production, TICAM) and the ones that are targeted with other
modules (e.g. PDK1 for ROS, Early endosome for IFR7, or MyD88 for AP-1 and AP-1(2)). For n§2, the distributions do no show which combinations of
modules are hit together (see Fig. 2).
doi:10.1371/journal.pone.0031341.g003
Figure 4. Identification of Essential Gene Sets. Species X is
produced by two distinct reactions: R1 and R2. These reactions require
proteins P1 and P2 to be expressed, respectively. The proteins can be
used as enzymes or substrates. P1 is a dimer coded by genes A and B,
while P2 is coded by gene C. Species X is no longer produced if both
P1 and P2 are absent. Hence, the deletion of genes A and C, or B and C
renders reaction RX non-producible.
doi:10.1371/journal.pone.0031341.g004
Controlling the Outcome of the Toll-Like Receptor
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e31341not exhaustively describe the pathways present in the immune
system. Consequently, some crosstalk pathways, which may be
affecting the producibility of the network’s outputs, are potentially
missing from the ihsTLR v1.0 model. Some EGS found from our
computational results may prove to be irrelevant in vivo due to
these missing components. Moreover, since the model is human
centered, the mouse results must be interpreted with additional
caution, although most of the TLR pathways are conserved
between the human and mouse. Finally, a non-uniform gene
nomenclature makes it difficult to exhaustively construct the GPR
associations. We also want to emphasize that transient behaviors of
the network do not affect the producibility of the outputs.
A valuable piece of information that we provide along with the
EGS is the impact they have. Species, reaction, and module
impacts were computed for every EGS. These numbers enable to
choose gene sets whose knockout will have a minimal impact on
the network. These EGS target a specific set of outputs while
affecting the minimum number of species, reactions, and
modules. We enumerated 801 EGS that targeted the power set
of outputs with minimal impact, in both human and mouse
(Dataset S2). Note that a minimal impact does not guarantee that
the knockout will not be lethal for the cell. Linking the TLR
network with a metabolic network could provide an answer to
such a question. The integration of multiple systems is an efficient
way to improve biological predictions of computational models
[20,34,35].
Searching essential reactions or genes (i.e. MCS or EGS) for an
objective has two applications. Firstly, this information can be used
to disable the objective. Secondly, it can identify key elements to
maintain in order to conserve the objective. Given the current
literature, we can conjecture on the effect of disabling any of the
outputs of the TLR network. NF-kB is involved in a multitude of
cellular processes: inflammation, T- and B-cells development,
hematopoeitic cells survival, nitric oxide regulation, and lymphoid
organogenesis [14]. Moreover, NF-kB is involved in the activation
of other TFs present in the network. Hence, knocking out NF-kB
may provoke serious repercussions on the host. In this case, the
EGS identify deletions to avoid at all cost, or sets of genes that
should not be targeted simultaneously in order to preserve the
activity of NF-kB. The knockout of AP-1 deregulates cell cycle and
proliferation, and interferes with lymphoid cells development [11].
Here again, disabling AP-1 risks to provoke some unwanted
consequences such as oncogenesis. Among all the outputs, ROS
may be the one whose disabling causes the least side effects as it is
the only one not being a TF. As a matter of fact, the oxidative
burst generated by ROS provokes collateral damage to the host by
itself [15]. Hence, blocking the formation of the NADPH oxidase
complex would protect the organism from such damage, while
depriving it of the positive effects of the burst.
We studied epistatic relations between modules of the ihsTLR
v1.0 model, and determined knockout strategies to control the
outcome of the TLR pathways. Analysis of the model suggests that
the manipulation of the response of these pathways is best
achieved by disabling targets downstream of the TLRs. We
extended the Minimal Cut Sets to the notion of Essential Gene
Sets (EGS), and determined lists of genes whose deletion perturbs
combinations of the network’s outputs. In addition, we assessed the
impact of such deletions and provided the EGS that have minimal
impact on adjacent pathways.
Materials and Methods
Signaling model
We represent a mass-balanced signaling network involving m
species and n reactions with a stoichiometric matrix S[R
m|n. The
stoichiometric matrix comprises the biochemical reactions occur-
ring within the TLR pathways: receptor/ligand binding, phos-
phorylation cascades, activation of TFs. Each entry Sij specifies
the stoichiometric coefficient for species i in reaction j.W e
represent the flux distribution through all the reactions by v[R
n,
where the j-th component vj represents the flux through reaction j.
We consider all reactions to be irreversible (i.e. v§0) by breaking
all reversible reactions into two irreversible ones. The concentra-
tion of each species in the system at time t is given by x(t)[R
m
z.
Under these assumptions, the change of concentration of species in
time is given by
_ x x~Sv,v§0: ð1Þ
Chemical reactions occurring in signaling networks (e.g.
phosphorylation, transport, etc) take less than 1 sec, while
transcriptional regulation and receptor internalization take on
the order of 102 sec [18,19]. This difference in time scales justifies
the quasi-steady state assumption suggested by Li et al. [10], under
which the fast signaling dynamics are assumed in steady state. This
assumption is usually used in the study of metabolic networks,
when the dynamics of the (fast) metabolic reactions are assumed in
quasi-steady state when compared to the slow gene regulation
Table 4. EGS validation.
Genes in EGS Outputs targeted Reference to validation experiments
MAPK8 AP1, AP1(2) De ´rijard et al. (1994) JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and
phosphorylates the c-Jun activation domain, Cell 76: 1025–1037
TBK1, IKKE IRF3, IRF7 *Sharma et al. (2003) Triggering the interferon antiviral response through an IKK-related pathway,
Science 300: 1148–51
TRAF6 IRF7 *Kawai et al. (2004) Interferon-a induction through Toll-like receptors involves a direct interaction
of IRF7 with MyD88 and TRAF6, Nat Immunol 5:1061–8
MyD88 IRF7 *Kawai et al. (2004) Interferon-a induction through Toll-like receptors involves a direct interaction
of IRF7 with MyD88 and TRAF6, Nat Immunol 5:1061–8
b-TrCP NF-kB(2) Wu et al. (1999) b-TrCP mediates the signal-induced ubiquitination of IkBb, J Biol Chem 274: 29591–4
Vav1 ROS, ROS(2) Kim et al. (2003) The hemopoietic Rho/Rac guanine nucleotide exchange factor Vav1 regulates
N-formyl-methionyl-leucyl-phenylalanine-activated neutrophil functions, J Immunol 171: 4425–30
Experimental validations of the predictions are found in the cited publications. A complete list of the EGS is shown in Table S2.
*These articles were also used for the reconstruction of the ihsTLR v1.0 model [10].
doi:10.1371/journal.pone.0031341.t004
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Equation (1) becomes:
Sv~0,v§0: ð2Þ
All 14 inputs I of the ihsTLR v1.0 model were considered active,
i.e. vI§0, where vI is the vector of all vi,i[I. The inputs are 11
TLRs (TLR1 through TLR11), IL1R1, NOD1, and NOD2. Nine
output reactions are defined in the model (Table 1). An output j is
considered producible if and only if
Av[K s:t: vjw0,
K~fv[R
njSv~0,v§0g:
ð3Þ
The set K from Equation (3) is called the feasible flux cone of S.
Minimal Cut Sets
Initially defined for metabolic networks, a cut set for an
objective reaction is a set of reactions whose knockout disables that
function [25]. Formally, C is a cut set for the objective reaction j in
model S if and only if vj is producible in the wild type (i.e. Av[K
such that vjw0) and
vC~0?vj~0,Vv[K: ð4Þ
A cut set is considered minimal if none of its subset is a cut set
for that reaction (Fig. 1). MCS can be generated in a ‘‘brute force’’
way by performing all knockout combinations and by testing (e.g.
using FBA) if the maximum flux through the objective reaction is
zero. This method becomes rapidly infeasible for large networks
and MCS of high cardinality. Alternatively, MCS can be
constructed as minimal hitting sets of extreme pathways (EP)
[25], which are the generators of the polyhedral cone from
Equation (3). A hitting set for an objective reaction j is a set that
intersects all j-containing EP. This method has previously been
employed to study epistasis in the E. coli and human metabolism
[25–27]. We generated MCS following the algorithm detailed by
Imielinski [26]. In summary, to compute MCS for a target
reaction j, the algorithm performs three main steps: (1) generation
of EP for an ‘‘over-approximated’’ cone K that includes the
feasible flux cone K, (2) computation of minimal hitting sets for
reaction j in K, and (3) reduction of the above sets to minimality.
As proved in [26], the sets obtained at (3) are guaranteed to be
MCS for reaction j in K. However, the approach is not complete,
in the sense that it might miss some MCS.
Essential Gene Sets
We constructed EGS iteratively for each MCS of all outputs.
For each reaction in an MCS, we first identified combinations of
genes whose deletion disabled that reaction. This was done by
searching genes coding for proteins used in that reaction. We
initially had to identify these genes in human and mouse through
searches in the literature and in the Entrez Gene and MGI
databases (Dataset S1). Similar sets of rules, usually called Gene-
Protein-Reaction (GPR) associations, are present in many
metabolic models [17], but were absent from the ihsTLR v1.0
model. Several combinations of genes may exist as different gene
deletions can have the same effect over a reaction. We denote as
Gj the set of all combinations for reaction j. Once we obtained
the sets Gj for all reactions in an MCS, we take their Cartesian
product to construct EGS for the corresponding objective
reaction. In the example from Figure 4, deleting A or B stops
R1 (G1 =f(A), (B)g)a n dd e l e t i n gCs t o p sR2 (G2 =f(C)g). We
obtain EGS for RX by taking the Cartesian product of G1 and
G2:E G S RX =f(A,C), (B,C)g. Note that the sets Gj cannot be
constructed for every reaction; at least one of the reaction
substrates must be coded by a known gene. If at least one reaction
cannot be disabled by gene deletion than no EGS can be
generated. As MCS, EGS are considered to be minimal, i.e. no
subset of an EGS is itself an EGS. We consider an EGS for a set
of outputs as a set of genes whose deletion renders all the
corresponding outputs non-producible.
Estimation of gene deletions impact
In metabolic networks, the lethality of a gene deletion can be
assessed by checking whether it disables the production of a
biomass component. The ihsTLR v1.0 model does not include
such an objective function. Moreover, this approach is relevant for
the study of unicellular organisms, but for more complex
organisms, the producibility of the biomass is only necessary, but
not sufficient for survival. This motivated us to compute several
estimates for the impact of the deletion of an EGS: the species,
reaction, and module impacts (Dataset S2). We define these impacts
as the number of species, reactions, and modules, respectively, that
are no longer producible or affected upon deletion of all the genes
in an EGS. The three estimates allow us to evaluate the global
impact of gene deletions.
We determined which EGS have the ‘‘minimal’’ impact on the
network based on the three impact values. Among all the EGS that
knock out the same set of outputs, we first identified the ones that
disabled either the minimum number of species (i.e. Es), reaction
(i.e. Er), or module (i.e. Em). Then, taking the intersection
Es\Er\Em gave us the EGS with minimal impact. If this
intersection is empty then no ‘‘minimal’’ EGS can be found.
Supporting Information
Figure S1 Classification of the MCS according to their
cardinality and to the number of modules they target. In
each plot, the size of the dots shows the number of MCS
containing x reactions that hit y modules. x and y are given on the
x- and y-axis, respectively. xƒy for all outputs since a reaction
belongs to a single module. Having xvy indicates that several
reactions target the same module. The legend on the top-right
corner provides with an estimate of the number of MCS according
the size of the dot.
(TIF)
Table S1 Modules of the TLR network. Function and
description of the modules involved in the TLR network. Only
modules hit by MCS are listed.
(PDF)
Table S2 EGS validation. List of the initial EGS obtained
from our computation. Experimental validations of the predictions
are found it the cited publications.
(PDF)
Dataset S1 GPR associations of the TLR network. List of
the genes coding for the proteins of the TLR network. Entrez
Gene ID are given for human and mouse.
(XLS)
Dataset S2 EGS with minimal side effect. List of the EGS
that target the power set of outputs with minimal side effect in
human (first sheet) and in mouse (second sheet). Each set of genes
is followed by its respective species, reaction, and module impacts.
(XLS)
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